TY - JOUR
T1 - Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model
AU - Hachem, Ray
AU - Parikh, Umang M.
AU - Reitzel, Ruth
AU - Rosenblatt, Joel
AU - Kaul, Aditya
AU - Vargas-Cruz, Nylev
AU - Hill, Lori
AU - Moore, Lisa
AU - Meyer, Jennifer
AU - Chaftari, Anne Marie
AU - Gagea, Mihai
AU - Balaji, Swathi
AU - Raad, Issam I.
N1 - Funding Information:
No honoraria or extramural funding was received. These studies were supported by the Department of Infectious Diseases, Infection Control & Employee Health at HMRI (RH), and the Department of Surgery, Pediatric Surgery at Texas Children's Hospital (SB).
Publisher Copyright:
© 2021 The Wound Healing Society.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Microbial contamination of wounds is a significant problem that delays healing, particularly when bacterial biofilms are present. A novel combination of pectinic acid (PG) + caprylic acid (CAP) was previously found in vitro to be highly effective in eradicating various pathogens in biofilms with minimal cytotoxicity. In this study, a novel wound ointment was formulated with PG + CAP and first assessed in vitro using a well-established biofilm eradication model. In vitro, the PG + CAP ointment was shown to be efficacious in reducing the microbial biofilms. This ointment was then tested in vivo in two pilot porcine wound healing models, with and without Staphylococcus aureus microbial challenge. Ointments were applied to each wound daily, and healing by wound closure area measurement was assessed weekly over 4 weeks. After 4 weeks, pigs were sacrificed and wounds were scored for reepithelialization, inflammation, granulation tissue, and collagen deposition. We compared PG + CAP to hydroxyethylcellulose + glycerol ointment base (control) and MediHoney (comparator). In the porcine microbial challenge model, the novel antimicrobial PG + CAP wound ointment rapidly eradicated bacterial organisms embedded in wounds, was safe and well-tolerated, and was associated with enhanced healing compared to ointment base and MediHoney. Specifically, the cumulative histopathology, reepithelialization of epidermis, and mature granulation tissue in the wound bed was significantly better with PG + CAP than with control and MediHoney treatments. This ointment warrants further study as a non-antibiotic ointment for use in treating a wide array of infected wounds.
AB - Microbial contamination of wounds is a significant problem that delays healing, particularly when bacterial biofilms are present. A novel combination of pectinic acid (PG) + caprylic acid (CAP) was previously found in vitro to be highly effective in eradicating various pathogens in biofilms with minimal cytotoxicity. In this study, a novel wound ointment was formulated with PG + CAP and first assessed in vitro using a well-established biofilm eradication model. In vitro, the PG + CAP ointment was shown to be efficacious in reducing the microbial biofilms. This ointment was then tested in vivo in two pilot porcine wound healing models, with and without Staphylococcus aureus microbial challenge. Ointments were applied to each wound daily, and healing by wound closure area measurement was assessed weekly over 4 weeks. After 4 weeks, pigs were sacrificed and wounds were scored for reepithelialization, inflammation, granulation tissue, and collagen deposition. We compared PG + CAP to hydroxyethylcellulose + glycerol ointment base (control) and MediHoney (comparator). In the porcine microbial challenge model, the novel antimicrobial PG + CAP wound ointment rapidly eradicated bacterial organisms embedded in wounds, was safe and well-tolerated, and was associated with enhanced healing compared to ointment base and MediHoney. Specifically, the cumulative histopathology, reepithelialization of epidermis, and mature granulation tissue in the wound bed was significantly better with PG + CAP than with control and MediHoney treatments. This ointment warrants further study as a non-antibiotic ointment for use in treating a wide array of infected wounds.
KW - MediHoney
KW - antimicrobial ointment
KW - in vivo porcine model
KW - infection
KW - wound healing
KW - wound-bed preparation
UR - http://www.scopus.com/inward/record.url?scp=85105648777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105648777&partnerID=8YFLogxK
U2 - 10.1111/wrr.12922
DO - 10.1111/wrr.12922
M3 - Article
C2 - 33956391
AN - SCOPUS:85105648777
SN - 1067-1927
VL - 29
SP - 830
EP - 842
JO - Wound Repair and Regeneration
JF - Wound Repair and Regeneration
IS - 5
ER -